Tapewire

Nasdaq · USD

UTHR

UNITED THERAPEUTICS Corp

Export transactions ↓
Tapewire entity
664
SEC CIK
0001082554
Parsed reports
1,261

Last 12 months

Inside the activity.

1 purchase rows · 2632 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 20250142
Dec 20250143
Jan 2026078
Feb 2026026
Mar 20260364
Apr 20260346
May 20261340
Jun 20260298
Jul 20260240
Aug 20260251
Sep 20260260
Oct 20260144

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 14, 2024 Filed May 15, 2024 20:30 UTC Exercise / conversionCommon Stock 1,310 $76.26 $99,900.60
Disclosure

SEC source: 0001415889-24-013238 · form4-05152024_040522.xml · nonDerivative · entry 1

PATUSKY CHRISTOPHER · CIK 0001231427 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,310

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects an adjustment to total holdings to exclude four shares incorrectly included in prior reports due to administrative error.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 3,600 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-013351 · form4-05162024_040504.xml · derivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 252,269

Underlying: Common Stock · 3,600 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 379 $269.32 $102,072.55
Disclosure

SEC source: 0001415889-24-013351 · form4-05162024_040504.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $269.23 to $269.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,353 $268.41 $363,153.18
Disclosure

SEC source: 0001415889-24-013351 · form4-05162024_040504.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 509

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $268.04 to $268.925. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,083 $267.53 $289,731.42
Disclosure

SEC source: 0001415889-24-013351 · form4-05162024_040504.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,862

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $266.93 to $267.915. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 754 $266.34 $200,817.34
Disclosure

SEC source: 0001415889-24-013351 · form4-05162024_040504.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,945

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $265.90 to $266.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 31 $264.35 $8,194.85
Disclosure

SEC source: 0001415889-24-013351 · form4-05162024_040504.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,699

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 14, 2024 Filed May 16, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 3,600 $129.49 $466,164.00
Disclosure

SEC source: 0001415889-24-013351 · form4-05162024_040504.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,730

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 13, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 3,600 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · derivative · entry 14

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 255,869

Underlying: Common Stock · 3,600 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 13, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 180 $268.89 $48,399.30
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 13, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 251 $267.84 $67,228.17
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 310

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F10 · price: This transaction was executed in multiple trades at prices ranging from $267.54 to $267.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 13, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 647 $266.56 $172,463.48
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 561

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F9 · price: This transaction was executed in multiple trades at prices ranging from $266.03 to $267.025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 13, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 850 $265.40 $225,589.15
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,208

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $265.01 to $266.005. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 13, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,672 $264.39 $442,064.43
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,058

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $263.96 to $264.755. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 13, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 3,600 $129.49 $466,164.00
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,730

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 3,600 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · derivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 259,469

Underlying: Common Stock · 3,600 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 114 $269.13 $30,680.61
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $268.94 to $269.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 224 $268.10 $60,053.62
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 244

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $267.865 to $268.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 619 $267.02 $165,284.14
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 468

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $266.59 to $267.555. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 894 $265.40 $237,266.97
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,087

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $265.08 to $266.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,749 $264.44 $462,502.24
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,981

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $264.015 to $264.985. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 10, 2024 Filed May 14, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 3,600 $129.49 $466,164.00
Disclosure

SEC source: 0001415889-24-013129 · form4-05142024_040509.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,730

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 09, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 3,600 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · derivative · entry 16

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 263,069

Underlying: Common Stock · 3,600 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 09, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 682 $265.82 $181,285.97
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 14

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F12 · price: This transaction was executed in multiple trades at prices ranging from $265.50 to $266.005. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 09, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,103 $265.21 $292,530.38
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 13

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 812

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F11 · price: This transaction was executed in multiple trades at prices ranging from $264.50 to $265.485. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 09, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 562 $263.98 $148,355.58
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 12

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,915

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F10 · price: This transaction was executed in multiple trades at prices ranging from $263.44 to $264.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 09, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,006 $262.79 $264,361.91
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 11

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,477

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F9 · price: This transaction was executed in multiple trades at prices ranging from $262.35 to $263.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 09, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 247 $261.83 $64,672.55
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 10

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,483

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F8 · price: This transaction was executed in multiple trades at prices ranging from $261.215 to $262.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 09, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 3,600 $129.49 $466,164.00
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 9

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,730

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 3,600 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · derivative · entry 15

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 266,669

Underlying: Common Stock · 3,600 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 29 $268.30 $7,780.70
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 8

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 253 $266.58 $67,444.54
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 159

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F7 · price: This transaction was executed in multiple trades at prices ranging from $266.38 to $266.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 113 $266.10 $30,069.30
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 412

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $265.265 to $266.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 713 $264.75 $188,764.04
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 525

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $264.21 to $265.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 223 $263.10 $58,670.70
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,238

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $263.06 to $263.975. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 1,430 $262.38 $375,204.12
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,461

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $261.93 to $262.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 839 $261.33 $219,253.10
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,891

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $260.85 to $261.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 3,600 $129.49 $466,164.00
Disclosure

SEC source: 0001415889-24-012874 · form4-05102024_040510.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,730

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 07, 2024 Filed May 8, 2024 20:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 3,600 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-012596 · form4-05082024_040550.xml · derivative · entry 7

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 270,269

Underlying: Common Stock · 3,600 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 07, 2024 Filed May 8, 2024 20:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 811 $266.13 $215,828.10
Disclosure

SEC source: 0001415889-24-012596 · form4-05082024_040550.xml · nonDerivative · entry 6

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F6 · price: This transaction was executed in multiple trades at prices ranging from $265.54 to $266.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 07, 2024 Filed May 8, 2024 20:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 315 $264.91 $83,446.30
Disclosure

SEC source: 0001415889-24-012596 · form4-05082024_040550.xml · nonDerivative · entry 5

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 941

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F5 · price: This transaction was executed in multiple trades at prices ranging from $264.54 to $265.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 07, 2024 Filed May 8, 2024 20:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 927 $263.97 $244,701.95
Disclosure

SEC source: 0001415889-24-012596 · form4-05082024_040550.xml · nonDerivative · entry 4

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,256

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F4 · price: This transaction was executed in multiple trades at prices ranging from $263.44 to $264.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 07, 2024 Filed May 8, 2024 20:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 930 $262.73 $244,334.25
Disclosure

SEC source: 0001415889-24-012596 · form4-05082024_040550.xml · nonDerivative · entry 3

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,183

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F3 · price: This transaction was executed in multiple trades at prices ranging from $262.25 to $263.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 07, 2024 Filed May 8, 2024 20:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 617 $261.63 $161,426.64
Disclosure

SEC source: 0001415889-24-012596 · form4-05082024_040550.xml · nonDerivative · entry 2

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,113

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $261.20 to $261.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 07, 2024 Filed May 8, 2024 20:31 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionCommon Stock 3,600 $129.49 $466,164.00
Disclosure

SEC source: 0001415889-24-012596 · form4-05082024_040550.xml · nonDerivative · entry 1

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,730

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:30 UTC
BENKOWITZ MICHAELPRESIDENT AND COO
Exercise / conversionShare Tracking Award · Derivative 32,200 $0.00 Strike: $163.30 $0.00
Disclosure

SEC source: 0001415889-24-012466 · form4-05072024_040513.xml · derivative · entry 3

BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,200 shares

Expires 2025-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:30 UTC
BENKOWITZ MICHAELPRESIDENT AND COO
Disposition to issuerCommon Stock 32,200 $260.51 $8,388,422.00
Disclosure

SEC source: 0001415889-24-012466 · form4-05072024_040513.xml · nonDerivative · entry 2

BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,577

F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:30 UTC
BENKOWITZ MICHAELPRESIDENT AND COO
Exercise / conversionCommon Stock 32,200 $163.30 $5,258,260.00
Disclosure

SEC source: 0001415889-24-012466 · form4-05072024_040513.xml · nonDerivative · entry 1

BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,777

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.

F2 · balance_after: Includes 118, 113, and 111 shares of common stock acquired on March 4, 2022, March 3, 2023, March 4, 2024, respectively, under the United Therapeutics Corporation Employee Stock Purchase Plan.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
Exercise / conversionStock Options · Derivative 3,600 $0.00 Strike: $129.49 $0.00
Disclosure

SEC source: 0001415889-24-012465 · form4-05072024_040508.xml · derivative · entry 17

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 273,869

Underlying: Common Stock · 3,600 shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

Read SEC document
May 06, 2024 Filed May 7, 2024 20:30 UTC
ROTHBLATT MARTINE ADirector · CHAIRPERSON & CEO
SaleCommon Stock 142 $264.14 $37,507.78
Disclosure

SEC source: 0001415889-24-012465 · form4-05072024_040508.xml · nonDerivative · entry 15

ROTHBLATT MARTINE A · CIK 0001106578 · Director · CHAIRPERSON & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130

F1 · kind: This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.

F14 · price: This transaction was executed in multiple trades at prices ranging from $263.48 to $264.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.